These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10869862)

  • 41. Sodium oxybate in maintaining alcohol abstinence in alcoholic patients with and without psychiatric comorbidity.
    Caputo F; Francini S; Brambilla R; Vigna-Taglianti F; Stoppo M; Del Re A; Leggio L; Addolorato G; Zoli G; Bernardi M
    Eur Neuropsychopharmacol; 2011 Jun; 21(6):450-6. PubMed ID: 21276717
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of Gamma-Hydroxybutyric Acid-Use and Gamma-Hydroxybutyric Acid-Induced Coma on Affect and the Affective Network.
    Raposo Pereira F; McMaster MTB; de Vries YDAT; Polderman N; van den Brink W; van Wingen GA
    Eur Addict Res; 2019; 25(4):173-181. PubMed ID: 30999293
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Overview of pharmacologic treatment approaches for alcohol and other drug addiction. Intoxication, withdrawal, and relapse prevention.
    Gorelick DA
    Psychiatr Clin North Am; 1993 Mar; 16(1):141-56. PubMed ID: 8456040
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sodium oxybate in maintaining alcohol abstinence in alcoholic patients according to Lesch typologies: a pilot study.
    Caputo F; Del Re A; Brambilla R; Grignaschi A; Vignoli T; Vigna-Taglianti F; Addolorato G; Zoli G; Cibin M; Bernardi M
    J Psychopharmacol; 2014 Jan; 28(1):23-30. PubMed ID: 24045881
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sodium oxybate in the treatment of alcohol dependence: from the alcohol withdrawal syndrome to the alcohol relapse prevention.
    Skala K; Caputo F; Mirijello A; Vassallo G; Antonelli M; Ferrulli A; Walter H; Lesch O; Addolorato G
    Expert Opin Pharmacother; 2014 Feb; 15(2):245-57. PubMed ID: 24283802
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study.
    Addolorato G; Caputo F; Capristo E; Domenicali M; Bernardi M; Janiri L; Agabio R; Colombo G; Gessa GL; Gasbarrini G
    Alcohol Alcohol; 2002; 37(5):504-8. PubMed ID: 12217947
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification.
    Wilde MI; Wagstaff AJ
    Drugs; 1997 Jun; 53(6):1038-53. PubMed ID: 9179530
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gamma-hydroxybutyric acid in the right hands.
    Feldman NT
    South Med J; 2000 Oct; 93(10):1037-8. PubMed ID: 11147473
    [No Abstract]   [Full Text] [Related]  

  • 49. Sodium Oxybate Therapy for Alcohol Withdrawal Syndrome and Keeping of Alcohol Abstinence.
    Mannucci C; Pichini S; Spagnolo EV; Calapai F; Gangemi S; Navarra M; Calapai G
    Curr Drug Metab; 2018; 19(13):1056-1064. PubMed ID: 29219048
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.
    Addolorato G; Balducci G; Capristo E; Attilia ML; Taggi F; Gasbarrini G; Ceccanti M
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacological treatment of alcohol dependence: a review of the evidence.
    Garbutt JC; West SL; Carey TS; Lohr KN; Crews FT
    JAMA; 1999 Apr; 281(14):1318-25. PubMed ID: 10208148
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gamma-hydroxybutyric acid (GHB) withdrawal: a case report.
    Bennett WR; Wilson LG; Roy-Byrne PP
    J Psychoactive Drugs; 2007 Sep; 39(3):293-6. PubMed ID: 18159783
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gabapentin reduces alcohol consumption and craving: a randomized, double-blind, placebo-controlled trial.
    Furieri FA; Nakamura-Palacios EM
    J Clin Psychiatry; 2007 Nov; 68(11):1691-700. PubMed ID: 18052562
    [TBL] [Abstract][Full Text] [Related]  

  • 54. gamma-Hydroxybutyric acid in the treatment of alcohol dependence: possible craving development for the drug.
    Addolorato G; Caputo F; Stefanini GF; Gasbarrini G
    Addiction; 1997 Aug; 92(8):1035-6. PubMed ID: 9376774
    [No Abstract]   [Full Text] [Related]  

  • 55. Decision rules for GHB (γ-hydroxybutyric acid) detoxification: a vignette study.
    Kamal RM; van Iwaarden S; Dijkstra BA; de Jong CA
    Drug Alcohol Depend; 2014 Feb; 135():146-51. PubMed ID: 24380737
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Medications for alcohol use disorders: An overview.
    Akbar M; Egli M; Cho YE; Song BJ; Noronha A
    Pharmacol Ther; 2018 May; 185():64-85. PubMed ID: 29191394
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gamma-hydroxybutyric acid in alcohol preference, dependence and withdrawal.
    Colombo G; Gessa GL
    Addict Biol; 2000 Oct; 5(4):389-403. PubMed ID: 20575856
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Benzodiazepine treatment for alcohol-dependent patients.
    Lejoyeux M; Solomon J; Adès J
    Alcohol Alcohol; 1998; 33(6):563-75. PubMed ID: 9872344
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of acamprosate and different kinds of psychosocial support in relapse prevention of alcoholism. Results from a non-blind, multicentre study.
    Soyka M; Preuss U; Schuetz C
    Drugs R D; 2002; 3(1):1-12. PubMed ID: 11881521
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Severe illicit gamma-hydroxybutyric acid withdrawal in a pregnant woman: what to do?
    van Mechelen JC; Dijkstra B; Vergouwen A
    BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31796453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.